Back to top

A SPECIAL WELCOME GIFT FROM ZACKS.COM

Zacks' 7 Strongest Buys for July, 2025

See our "best of the best" short-term stocks. Hand-picked from 220 new Strong Buys, they could be the most profitable stocks you own over the next 90 days. Recent picks have climbed as much as +67.5% in 1 month. Our new recommendations may soar just as high.

A SPECIAL WELCOME GIFT FROM ZACKS.COM

Zacks' 7 Strongest Buys for July, 2025

See our "best of the best" short-term stocks. Hand-picked from 220 new Strong Buys, they could be the most profitable stocks you own over the next 90 days. Recent picks have climbed as much as +67.5% in 1 month. Our new recommendations may soar just as high. Today's market dip makes now an ideal time to get in.

No cost. No credit card. No obligation to buy anything ever. Past performance is no guarantee of future results.
We respect your privacy. Zacks Ultimate Member? Click here.

loading...

Zacks Private Picks

Click for the easiest, most affordable way to get the 'Best of Our Best.

Click for the easiest, most affordable way to get the 'Best of Our Best.

Is Coinbase (COIN) Stock Poised for Higher Highs?

Many positive catalysts have pushed Coinbase (COIN) stock higher, which hit a new 52-week high of $369 a share on Wednesday.

Many positive catalysts have pushed Coinbase (COIN) stock higher, which hit a new 52-week high of $369 a share on Wednesday.

Top Research Reports for Apple, AMD & Applied Materials

AAPL, AMD and AMAT lead today's top research picks, with insights on growth drivers, challenges, and shifting tech demand.

AAPL, AMD and AMAT lead today's top research picks, with insights on growth drivers, challenges, and shifting tech demand.

New Strong Buy Stocks for June 25th

This leader in the use of crystallography and structure-based drug design for the development of novel therapeutics has seen the Zacks Consensus Estimate for its next year earnings increase 78.3% over the last 60 days.

This leader in the use of crystallography and structure-based drug design for the development of novel therapeutics has seen the Zacks Consensus Estimate for its next year earnings increase 78.3% over the last 60 days.

Best-Performing Dividend ETFs of 1H

FDD and EFAS surged over 30% in H1 2025 as investors turned to global dividend ETFs amid U.S. market volatility.

FDD and EFAS surged over 30% in H1 2025 as investors turned to global dividend ETFs amid U.S. market volatility.

From Ashes to Glory: Is Carvana's Premium Valuation Worth It?

CVNA's soaring margins, digital edge, and bold growth plans fuel its premium - but can the company keep delivering to justify the hype?

CVNA's soaring margins, digital edge, and bold growth plans fuel its premium - but can the company keep delivering to justify the hype?

Defense ETFs Soar Amid Rising Global Tensions

Aerospace and defense ETFs have surged this year amid escalating geopolitical conflicts. We highlight five that are surging amid escalating global tensions.

Aerospace and defense ETFs have surged this year amid escalating geopolitical conflicts. We highlight five that are surging amid escalating global tensions.

›
‹

More Commentary

Investment Ideas

Stocks

More Stock Commentary

ETFs

More ETF Commentary

Mutual Funds

More Mutual Fund Commentary

Options

Earnings Analysis

More Analysis

Get the First Calendar Made for Traders.
Visit the Zacks Earnings Calendar

Reported Earnings Surprises

View All
Symbol Time Expected Reported %Surprise
MLKN 16:10 0.35 0.60 +71.43
SCS 16:12 0.12 0.20 +66.67
CULP 16:22 -0.10 -0.06 +40.00
WS 16:19 0.83 1.05 +26.51
MU 16:10 1.59 1.91 +20.13

EPS Positive Surprises for Jun 25, 2025

Symbol Time Expected Reported %Surprise
No EPS Negative Surprises for Jun 25, 2025

EPS Negative Surprises for Jun 25, 2025

Upcoming Earnings ESP

View More
Symbol ESP Most Accurate Estimate Consensus Estimate
MU 6.38% 1.69 1.59
JEF 8.24% 0.46 0.43
PRGS 0.46% 1.31 1.30
AYI 5.20% 4.65 4.42

Video Commentaries